Abstract
A rapid and simple microemulsion electrokinetic chromatography (MEEKC) method has been developed and validated for the determination of ethinylestradiol and levo-norgestrel in a commercial tablet formulation. The analysis was performed with an electrolyte composed of 0.5% (w/w) ethyl acetate, 1.2% (w/w) butan-1-ol, 0.6% (w/w) sodium dodecyl sulfate, 15% (v/v) ethanol and 82.7% (w/w) 12 mmol L−1 sodium tetraborate aqueous buffer at pH 9.23 and direct UV detection at 200 and 247 nm. For quantitative purposes, estrone was used as an internal standard. Retention time for levo-norgestrel and ethinylestradiol was approximately 2.1 and 2.5 min respectively. Acceptable precision (<0.90% RSD, linearity (r2 > 0.99; concentration range from 24.0 to 36.0 µg mL−1), limits of detection (LOD) and quatification (LOQ) for ethinylestradiol of 1.0 μg mL-1 and 3.2 µg mL−1, respectively, and for levo-norgestrel of 1.4 µg mL−1 and 4.1 µg mL-1, respectively, and recovery of 100 ± 2 % at three concentration levels were obtained. Based on the performance characteristics, the proposed methodology was found suitable for the determination of ethinylestradiol and levo-norgestrel in tablet formulations.
Keywords: Contraceptives, capillary electrophoresis, ethinylestradiol, levo-norgestrel, Microemulsion electrokinetic chromatography, steroids.
Current Analytical Chemistry
Title:Determination of Ethinylestradiol and Levo-Norgestrel Using Microemulsion Electrokinetic Chromatography
Volume: 10 Issue: 2
Author(s): Claudinei Alves da Silva, María Segunda Aurora-Prado and Marina Franco Maggi Tavares
Affiliation:
Keywords: Contraceptives, capillary electrophoresis, ethinylestradiol, levo-norgestrel, Microemulsion electrokinetic chromatography, steroids.
Abstract: A rapid and simple microemulsion electrokinetic chromatography (MEEKC) method has been developed and validated for the determination of ethinylestradiol and levo-norgestrel in a commercial tablet formulation. The analysis was performed with an electrolyte composed of 0.5% (w/w) ethyl acetate, 1.2% (w/w) butan-1-ol, 0.6% (w/w) sodium dodecyl sulfate, 15% (v/v) ethanol and 82.7% (w/w) 12 mmol L−1 sodium tetraborate aqueous buffer at pH 9.23 and direct UV detection at 200 and 247 nm. For quantitative purposes, estrone was used as an internal standard. Retention time for levo-norgestrel and ethinylestradiol was approximately 2.1 and 2.5 min respectively. Acceptable precision (<0.90% RSD, linearity (r2 > 0.99; concentration range from 24.0 to 36.0 µg mL−1), limits of detection (LOD) and quatification (LOQ) for ethinylestradiol of 1.0 μg mL-1 and 3.2 µg mL−1, respectively, and for levo-norgestrel of 1.4 µg mL−1 and 4.1 µg mL-1, respectively, and recovery of 100 ± 2 % at three concentration levels were obtained. Based on the performance characteristics, the proposed methodology was found suitable for the determination of ethinylestradiol and levo-norgestrel in tablet formulations.
Export Options
About this article
Cite this article as:
Silva Alves da Claudinei, Aurora-Prado Segunda María and Tavares Franco Maggi Marina, Determination of Ethinylestradiol and Levo-Norgestrel Using Microemulsion Electrokinetic Chromatography, Current Analytical Chemistry 2014; 10 (2) . https://dx.doi.org/10.2174/15734110113099990007
DOI https://dx.doi.org/10.2174/15734110113099990007 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel Chromeno[2,3-d]pyrimidines-Design, Synthesis and Antioxidant Activity
Letters in Drug Design & Discovery Molecular and Genetic Characterization of Natural Variants of HIV-1 Nef Gene from North India and its Functional Implication in Down-Regulation of MHC-I and CD-4
Current HIV Research Aptamers Overview: Selection, Features and Applications
Current Topics in Medicinal Chemistry Natural Products and their (Semi-)Synthetic Forms in the Treatment of Migraine: History and Current Status
Current Medicinal Chemistry Personalization of Targeted Therapy in Advanced Thyroid Cancer
Current Genomics Metabolism of Dietary Flavonoids in Liver Microsomes
Current Drug Metabolism Development of Agents that Modulate Protein-Protein Interactions in Membranes
Current Pharmaceutical Design Ca<sup>2+</sup>-Myristoyl Switch in Neuronal Calcium Sensor-1: A Role of C-Terminal Segment
CNS & Neurological Disorders - Drug Targets Evaluation of a Reporter Gene Assay for Bioactivity Determination of Therapeutic Interferons through a Collaborative Study
Current Pharmaceutical Analysis Therapeutic Potential of Antileukotriene Drug-<i>Camellia sinensis</i> Extract Co-Formulation on Histamine Induced Asthma in Guinea Pigs
Current Drug Research Reviews Chemical Structure and Surface Modification of Dendritic Nanomaterials Tailored for Therapeutic and Diagnostic Applications
Current Topics in Medicinal Chemistry Nanostructured Multiporphyrin Dendrimers: Synthesis, Characterization and Their Spectroscopic Properties
Current Organic Chemistry Serpin Regulation of Fibrinolytic System: Implications for Therapeutic Applications in Cardiovascular Diseases
Cardiovascular & Hematological Agents in Medicinal Chemistry Gender Based Differences in Stress-induced Gastric Ulcer Formation and its Regulation by Nitric Oxide (NO): An Experimental Study
Current Pharmaceutical Design iMethylK-PseAAC: Improving Accuracy of Lysine Methylation Sites Identification by Incorporating Statistical Moments and Position Relative Features into General PseAAC via Chou’s 5-steps Rule
Current Genomics Xenicane Natural Products: Biological Activity and Total Synthesis
Current Pharmaceutical Design Druggability of Mortalin for Cancer and Neuro-Degenerative Disorders
Current Pharmaceutical Design Lipidomics as Tools for Finding Biomarkers of Intestinal Pathology: From Irritable Bowel Syndrome to Colorectal Cancer
Current Drug Targets Prediction of Inhibition Activity of BET Bromodomain Inhibitors using Grid Search-Based Extreme Learning Machine and Molecular Docking
Letters in Drug Design & Discovery IAPs as a Target for Anticancer Therapy
Current Cancer Drug Targets